The Leverage Ratio of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) observed rebound of 10.26% since bottoming out on October 27, 2017. During the same quarter in the previous year, the company earned $1.07 EPS. A 15 analysts rate it as either a buy or a strong buy, while 0 believe that investors should either steer clear of (NASDAQ:WBA) or, if they already own its stock, sell it.
19 analysts on average are expecting Walgreens Boots Alliance, Inc.to report earnings of $1.21 per share for the current quarter. The Return on Equity ratio of Walgreens Boots Alliance, Inc. With the constructive P/E value of Walgreens Boots Alliance, Inc., the investors are able to forecast the positive earnings growth of the company. Finally, Loop Capital set a $90.00 price target on Walgreens Boots Alliance and gave the company a buy rating in a research report on Thursday, October 26th. Needham maintained it with "Buy" rating and $9400 target in Monday, July 17 report. This forecast is a point estimate that provides investors with a benchmark against which to directly compare stock price in the short run.Target prices made by analysts employed by large brokers, who have access to a greater resource pool, are more likely to be met over the 12-month forecast period. Morgan Stanley downgraded Walgreens Boots Alliance Inc (NASDAQ:WBA) on Friday, October 6 to "Equal-Weight" rating.
Walgreens Boots Alliance, Inc. has a 52-week low of $63.82 and a 52-week high of $88.00. The stock has a market capitalization of $71,667.88, a price-to-earnings ratio of 13.92, a P/E/G ratio of 1.26 and a beta of 1.20. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45. Walgreens Boots Alliance (WBA)'s Williams %R presently stands at -34.57. The pharmacy operator reported $1.31 EPS for the quarter, beating analysts' consensus estimates of $1.21 by $0.10.
The forward P/E of Walgreens Boots Alliance, Inc.is at 11.72 signifying the uses of estimated net earnings over the next 12 months. The company had revenue of $30.15 billion during the quarter, compared to analysts' expectations of $29.93 billion.
Senate approves Buhari's $5.5bn foreign loan request
Senate today approved the $5.5 billion external loan requested by President Muhammadu Buhari to finance Federal Government projects.
For the past 5 years, LendingClub Corporation's EPS growth has been almost -62.6%. Comparatively, WBA posted earnings of $0 per share in the same quarter, a year earlier. Pathstone Family Office LLC boosted its position in Walgreens Boots Alliance by 226.6% during the 2nd quarter. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and global copyright law. As per Wednesday, August 23, the company rating was maintained by UBS. This repurchase authorization authorizes the pharmacy operator to repurchase shares of its stock through open market purchases.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. The ex-dividend date is Friday, November 10th. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell. UTX trades with a P/S ratio of 1.59.
Asian stock markets were mixed Monday following Wall Street's losing week as investors looked ahead to a week of data releases and public comments by central bankers. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Similarly, the company's Director Lederer John Anthony on 2017-10-26 Buy 20000 shares of the company at a price of $67. Following the completion of the transaction, the director now owns 16,415 shares in the company, valued at $1,105,878.55. Alpha Beta Stock (ABS) makes sure to keep the information up to date and correct, but we didn't suggest or recommend buying or selling of any financial instrument unless that information is subsequently confirmed on your own. Hudock Capital Group LLC boosted its position in Walgreens Boots Alliance by 0.5% during the 2nd quarter. When we look at the Volatility of the company, Week Volatility is at 3.79% whereas Month Volatility is at 2.89%. Schwab Charles Investment Management Inc. grew its stake in shares of Walgreens Boots Alliance by 10.4% in the 3rd quarter. The stock remained 4.93% volatile for the week and 4.44% for the month. Finally, Nuveen Asset Management LLC raised its stake in Walgreens Boots Alliance by 21.1% in the first quarter. Walgreens Boots Alliance, Inc.'s ROA is rolling at 5.70%, following the ROI of 11.90%. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator's stock worth $107,000 after buying an additional 100 shares during the period. Pathstone Family Office LLC now owns 1,179 shares of the pharmacy operator's stock worth $1,969,000 after buying an additional 818 shares during the period. As the profitability measures are important to company managers and owners alike.